About Us

Home  /  About Us
best neurologist doctor in Gurgaon

Dr. Manish Mahajan

Multiple Sclerosis & Neuro Immunology

Dr. Manish Mahajan, a distinguished specialist in the field of neurology, possesses over 21 years of extensive experience. His remarkable journey in the medical realm began with the attainment of his MBBS degree from Govt Medical College Patiala in 2002.

Continuing his pursuit of knowledge, he pursued MD in General Medicine from the same institution in 2009, further augmenting his expertise. To further specialize in neurology, he obtained DNB in Neurology from Govt Medical College Patiala in 2013. He is best Neurology Doctor in Gurgaon.

Dr. Manish Mahajan’s knowledge and proficiency extend to the captivating domain of Multiple Sclerosis and Neuroimmunology. With his exceptional skills and passion for providing exceptional healthcare, he currently dedicates his services to the esteemed D Mettle Clinique. Situated at 303 A, 3rd Floor, Unitech Arcadia, South City II, Sector 49, Gurgaon, Haryana 122018, this medical establishment serves as the platform for Dr. Mahajan’s unwavering commitment to patient well-being.

1. MBBS – Govt Medical College Patiala – 2002

2. MD (Gen Medicine) – Govt Medical College Patiala – 2009

3. DNB (Neurology) – Govt Medical College Patiala – 2013

1. EDSS-certified examiner

2. Montreal Cognitive Assessment (MoCA) certified user

3. Medidata Rave Certified Principal Investigator

Active Member of the following bodies:

  1. Indian Academy of Neurology (IAN) – Life membership
  2. Neuroimmunology & Movement Disorder subsections of IAN
  3. American Academy of Neurology (AAN) since 2015
  4. European Academy of Neurology (EAN) since 2018
  5. International Parkinson and Movement Disorder Society (MDS)
  6. Indian Association of Physicians (API) Life membership

1. Bronze Medal in Pharmacology, 1999

2. Dr. A. D. Sehgal Award for the Best Resident-Neurology, 2012

3. The travel grant award for MDS-AOS Basic and Clinical Science School, and MDS- AOS Treatment for Advanced Parkinson’s Disease from August 8-10, 2019 in Seoul, South Korea.